Immunoassays: Page 5

Exposure to SARS-CoV-2 vaccination and infection may provide more durable immunity: Canadian study

By Jared Berberabe

Exposure to vaccination and infection "likely provides stronger, broader, and more durable hybrid immunity than either exposure alone, especially against severe outcomes,” the researchers said.

December 6, 2022

Bio-Techne releases next-generation mitochondrial imaging dyes

By LabPulse.com staff writers

The MitoBrilliant probes come in two types: the MitoBrilliant Live, which enables dynamic longer-term monitoring of mitochondrial membrane potential in live cells, and MitoBrilliant 646, to be used postfixation.

December 5, 2022

Pictor launches $5M financing round to support product, market development

By LabPulse.com staff writers

Pictor's multiplex technology enables testing for multiple diseases or different stages of a disease within a single enzyme-linked immunosorbent assay (ELISA) test well.

December 5, 2022

CorDx receives FDA Emergency Use Authorization for COVID-19 antigen test

By LabPulse.com staff writers

The COVID-19 Ag lateral flow immunoassay provides qualitative detection of the nucleocapsid protein antigen from the SARS-CoV-2 virus, providing a result in 10 minutes.

December 1, 2022

PerkinElmer launches adeno-associated virus vector detection kits for research

By LabPulse.com staff writers

The new kits use bead-based luminescent amplification to provide researchers with an option that is less time-consuming than ELISA and other wash-based tests, as well as having a wide detection range and high throughput.

November 21, 2022

Roche Diagnostics expands retail channel for COVID-19 at-home test

By LabPulse.com staff writers

Roche Diagnostics said that their over-the-counter test for SARS-CoV-2 has been rebranded as the Pilot COVID-19 At-Home Test.

November 10, 2022

Nanomix signs distribution agreement with Mast Group for immunoassay and chemistry diagnostic system

By LabPulse.com staff writers

Nanomix has signed an agreement with Mast Group, allowing the company to distribute Nanomix’s eLab system to the U.K., France, Germany, Ireland, and South Africa.

November 4, 2022

Lab-based immunoassay products market to reach $30.6B in 2022: Kalorama

By Leo O'Connor

The global market for lab-based immunoassay products is expected to grow at a compound annual growth rate (CAGR) of 2% between 2022 and 2027.

October 28, 2022

UCLA research shows rapid antigen tests may be effective tools for return-to-work programs

By Jared Berberabe

Researchers from UCLA conducted a study examining how antigen test results may be used to guide healthcare systems implementing return-to-work protocols.

October 24, 2022

Volition signs global supply agreement for pet cancer assay

By LabPulse.com staff writers

According to the agreement, the supplier will be engaged as a worldwide provider of the pet cancer assay through its reference laboratory network.

October 20, 2022

Nanomix, Diaclinic ink deal to distribute immunoassay in Chile

By LabPulse.com staff writers

The S1 Panel Cartridge running on the Nanomix diagnostic system provides test results for procalcitonin, C-reactive protein, and lactate from a single venous whole blood or plasma sample.

October 20, 2022

Abbott Q3 diagnostics revenues decline 6% on lower COVID testing demand

By LabPulse.com staff writers

Excluding COVID-19 testing-related sales, worldwide Diagnostics sales declined 0.2% on a reported basis and increased 6.1% on an organic basis in the third quarter.

October 19, 2022

Previous Page

Page 5 of 61

Next Page